Clinical Trial Update: A Study of Isoquercetin in People With Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating isoquercetin in patients with ovarian cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Ovarian Cancer
• Serous Ovarian Cancer

Drugs mentioned

• Isoquercetin (isoquercetin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Ovarian Cancer, Epithelial Ovarian Cancer | Phase 2 | Status: RECRUITING